A new partnership between Walmart and drug maker Eli Lily will make it easier for people to access the super-popular weight loss drug Zepbound.
Walmart Pharmacies to offer weight-loss drug making obesity treatment more accessible for millions nationwide.
Novo Nordisk made a surprise bid for Metsera to boost its weight-loss market lead, trading at just 12x 2026 EPS. Read why NVO ...
Novo Nordisk and Pfizer are showing some desperation in their gloves-off tussle for the obesity-drug assets of Metsera.
Scripps Research in La Jolla announce a new clinical trial that will assess the effectiveness of using drugs approved for ...
In late October 2025, Point32Health, Massachusetts’ second-largest health insurer, announced its second major round of ...
Popular weight-loss drugs like Ozempic and Zepbound may offer more than just help shedding extra pounds—they might also help protect people from serious health risks linked to sleep apnea. That’s the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback